An open randomised comparison of the clinical effectiveness and costs of protocol driven opioid analgesia, celiac plexus block, or thoracoscopic splanchnicectomy for pain relief in patients with abdominal malignancy

Not Applicable

Completed

• Conditions: Gastrointestinal cancer; Cancer

• Registration Number: ISRCTN91628176
• Lead Sponsor: niversity of Southampton (UK)

Brief Summary

2009 results in: http://www.ncbi.nlm.nih.gov/pubmed/20090396

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2003-04-25
• Study Completion: 2005-10-31
• Last Update Posted: 12 November 2018

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 330

Inclusion Criteria

Patients with gastrointestinal cancer

Exclusion Criteria

Not provided at time of registration

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To show better early pain relief when protocol driven opioid analgesia is supplemented with TS or CPB. This will be determined as the percentage of patients who obtain good pain relief 1 & 2 weeks after study entry (primary end point).

Secondary Outcome Measures

Name	Time	Method
ot provided at time of registration